cleveland clinic glp-1 Could medications help slow cancer progression? A new study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to patients Cleveland Clinic GLP-1 study shows

Whether that justification will hold up under increasing regulatory scrutiny is the billion-dollar question the entire industry is watching

Regulatory shifts in the US could expand access to peptides with limited clinical evidence, amplifying risks already driven by biohacking culture and grey-market supply chains In 2023, the United States (US) Food and Drug Administration (FDA) restricted the use of certain peptides by compounding pharmaciesfacilities that produce medications tailor-made to patientsowing to safety concerns

This depletion occurs because acetaminophen metabolism generates a reactive metabolite (NAPQI) that binds glutathione for neutralization and elimination

found that resveratrol alleviates excessive mitochondrial fission and promotes mitochondrial fusion in TGF-1-treated mesangial cells (Li et al., 2021b)

The trade-off is a higher incidence of gastrointestinal side effects

Thus, when prescribing antidepressants for fibromyalgia, shared decision making amongst patients and clinicians should be utilized, with a focus placed on which symptoms of fibromyalgia should be targeted